Aries Drugs Private Limited - Company Profile

It is a healthcare private limited company based in Rudrapur, Uttarakhand, India, established in 2005.
2005 Rudrapur, Uttarakhand, India Active
Last Updated:
Access Report
About Aries Drugs Private Limited

Aries Drugs Private Limited, a active private limited company, was established on 04 April 2005 in Rudrapur, Uttarakhand, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24232UR2005PTC007478. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.72 M.

It upholds a compliant status. Employing 21 professional, Its leadership includes Madan Lal Agarwal (Director), Ronak Agrawal (Director), Hari Om Agarwal (Director). Past directors included Rakesh Prakash Kaushik, Malvika Agarwal, Hari Om Agarwal. It holds no open charges and ₹4.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 90, Sector I.I.D.C., Sidcul I.I.E., Pant Nagar,, Rudrapur, Uttarakhand, 263145.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UR2005PTC007478

  • Registration Number

    007478

  • Incorporation Date

    04 April 2005

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.72 M

  • ROC Code

    Roc Uttarakhand

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.72 M
  • Company Age 21 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 4.50 M
  • Revenue Growth **** -22.96%
  • Profit Growth **** 34.79%
  • Ebitda **** -33.89%
  • Net Worth -40.69%
  • Total Assets -21.07%
Company report

Aries Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Aries Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aries Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Madan Lal Agarwal Director 02 May 2024 Current
Ronak Agrawal Director 02 May 2024 Current
Hari Om Agarwal Director 21 Jan 2019 Current
Amit Agarwal Managing Director 04 Apr 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Dec 2007 Past
Pramod Abcsdd Director 04 May 2024 Past
Pramod Abcsdd Managing Director 01 Nov 2010 Past
Pramod Abcsdd Director 07 Dec 2018 Past
Pramod Abcsdd Director 21 Jan 2019 Past
Pramod Abcsdd Director 25 Nov 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aries Drugs.

Aries Drugs Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 22.96% decrease. The company also saw a substantial improvement in profitability, with a 34.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.69%.

Aries Drugs revenue growth over time
Aries Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -22.96%
*******
*******
*******
*******
Revenue from Operations
*******
 -25.60%
*******
*******
*******
*******
Total Assets
*******
 -21.07%
*******
*******
*******
*******
Profit or Loss
*******
 34.79%
*******
*******
*******
*******
Net Worth
*******
 -40.69%
*******
*******
*******
*******
EBITDA
*******
 -33.89%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aries Drugs?

Unlock access to Aries Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹4,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.45 Cr
Latest Charge Details
Date Lender Amount Status
18 Jul 2008 Others ₹4.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aries Drugs?

Aries Drugs has a workforce of 21 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aries Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aries Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aries Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Aries Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Madan Lal Agarwal was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 2 years 2 months . was documented.

  • Director Appointment

    Progress on Ronak Agrawal was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 2 years 2 months . was documented.

  • Balance Sheet

    Progress on Aries Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was documented.

  • Director Appointment

    Progress on Hari Om Agarwal was appointed as a Director was appointed as a Director on 21 Jan 2019 & has been associated with this company since 7 years 5 months . was documented.

  • Charges

    The activity A charge registered on 18 Jul 2008 via Charge ID 10118420 with Others was fully satisfied on 18 Jun 2018. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aries Drugs Private Limited?

The CIN of Aries Drugs Private Limited is U24232UR2005PTC007478.

Where is Aries Drugs Private Limited headquartered?

Aries Drugs Private Limited is headquartered at Plot No. 90, Sector I.I.D.C., Sidcul I.I.E., Pant Nagar,, Rudrapur, Uttarakhand, 263145.

When was Aries Drugs Private Limited incorporated?

Aries Drugs Private Limited was incorporated on 04 April 2005.

Who are the current directors of Aries Drugs Private Limited?

The current directors of Aries Drugs Private Limited are

What is the primary industry of Aries Drugs Private Limited?

The primary industry of Aries Drugs Private Limited is Manufacturing.

Is Aries Drugs Private Limited a listed company?

Aries Drugs Private Limited is unlisted.

What is the capital structure of Aries Drugs Private Limited?

The authorized capital of Aries Drugs Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.72 M.

What is the compliance status of Aries Drugs Private Limited?

The compliance status of Aries Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available